• Members of the previous forum can retrieve their temporary password here, (login and check your PM).

Scientific Articles on DMT/Ayahuasca/Psychedelics

Migrated topic.
Does anyone here have access to pre-1991 volumes of the botanical journal Adansonia? (aka Bull. Museum National d'Histoire Naturelle Section B: Adansonia)
I need a copy of this -
Hartley, T. A revision of the genus Comptonella (Rutaceae). Adansonia 5(4):391-413 (1983/4).

Getting my hands on this is a big deal to me, which would end years of fruitless searching for the answer to a botanical mystery. Unfortunately the only on-line access is to volumes from 1991 onwards. No libraries in my country seem to have it... Can anyone please help?
 
Does anyone have acces to either of these?

Methodology for determining major constituents of ayahuasca and their metabolites in blood. McIlhenny, E. H., Riba, J., Barbanoj, M. J., Strassman, R. and Barker, S. A. (2012), Biomed. Chromatogr., 26: 301–313. doi: 10.1002/bmc.1657

Pharmacology of ayahuasca administered in two repeated doses.
Dos Santos RG, Grasa E, Valle M, Ballester MR, Bouso JC, Nomdedéu JF, Homs R, Barbanoj MJ, Riba J. Psychopharmacology (Berl). 2012 Feb;219(4):1039-53. Epub 2011 Aug 13.
 
alert said:
Does anyone have acces to either of these?

Methodology for determining major constituents of ayahuasca and their metabolites in blood. McIlhenny, E. H., Riba, J., Barbanoj, M. J., Strassman, R. and Barker, S. A. (2012), Biomed. Chromatogr., 26: 301–313. doi: 10.1002/bmc.1657

Pharmacology of ayahuasca administered in two repeated doses.
Dos Santos RG, Grasa E, Valle M, Ballester MR, Bouso JC, Nomdedéu JF, Homs R, Barbanoj MJ, Riba J. Psychopharmacology (Berl). 2012 Feb;219(4):1039-53. Epub 2011 Aug 13.

Here they are
 

Attachments

  • Pharmacology+repeated+doses+ayahuasca.pdf
    366 KB · Views: 0
  • Methodology+for+determining+blood+constituents.pdf
    543 KB · Views: 0
Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants, First Edition. Donald G. Barceloux. 2012

It has a lot of pharmacology and general info about these substances, history, analysis, etc. Generally some very good info and organized.. With few a bit off facts like 5-10g rue infusion as the general dose mentioned..

The chapters in that file:
1- Amphetamine and Methamphetamine
2- Methylphenidate
6- GHB and related substances
7- Ketamine
8- Methcathinone mephedrone and methylone
9- MDMA
10- Phenetylamine, piperazine and pyrrolidinophenone derivatives
11- Tryptamine Designer drugs
14- Serotoninergic and mixed agents
21- Ethanol
22- LSD
28- Buprenorphine
29- DXM
30- Fentanyl Analogues
31- Heroin and poppy
34- PCP and analogues
40- Nitrous oxide
45- Hexane
48- Toluene
52- Absinthe
53- Ayahuasca harmalas and DMT
54- Betel nut and areca
55- Caffeine
56- Cocaine
57- Ibogaine
58- Khat
59- Kratom
60- Marijuana and synthetic cannabinoids
61- Mate tea
62- Morning glory
63- Peyote and mescaline
64- Mushrooms and psilocybin
65- Salvia divinorum
66- Tobacco
 
Thanks Smerrel, for the link! I had hoped to find it by other means, but decided it's important enough to just bite the bullet and buy it.
 
This article isn't about psychedelics but I would still love to read it if anyone has access:

The Emerging Role of Meditation in Addressing Psychiatric Illness, with a Focus on Substance Use Disorders
Harvard Review of Psychiatry, 2009, Vol. 17, No. 4 : Pages 254-267
Elias Dakwar and Frances R. Levin
(doi: 10.1080/10673220903149135)
 
Would it be possible to aggregate all of these uploaded files, possibly in the Nexus Wiki?

We could sort them by subject, alphabetize them, generally make it a more organized resource.

Also, whenever I try to click any of the articles I get an error message saying: "Do not link directly to the resource, you must have a session in progress."

You guys are all amazing

Blessings
~ND
 
Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion

From the New Scientist article on the paper:

Draulio de Araujo of the Brain Institute at the Federal University of Rio Grande do Norte in Natal, Brazil, and colleagues recruited 10 frequent users of the brew – called ayahuasca. They asked the volunteers to look at images of people or animals while their brains were scanned using functional MRI, then asked the volunteers to close their eyes and imagine they were still viewing the image. Unsurprisingly, the researchers found that neural activity in the primary visual cortex dropped off when volunteers imagined seeing the image rather than actually viewing it.

But when the team then gave the volunteers a dose of ayahuasca and repeated the experiment, they found that the level of activity in the primary visual cortex was virtually indistinguishable when the volunteers were really viewing an image and when they were imagining it. This means visions seen have a real, neurological basis, says de Araujo – they are not made up or imagined.
 

Attachments

  • Seeing+With+the+Eyes+Shut-+Neural+Basis+of++Enhanced+Imagery+Following+Ayahuasca+Ingestion.pdf
    868.6 KB · Views: 0
I want to share these papers with you, the very first one is titled "Recreational use of naturally occurring dimethyltryptamine – contributing to psychosis?"

-Dos Santos et al. (2012) Pharmacology of ayahuasca administered in two repeated doses.
-Frecksa et al. (2013) A possibly sigma-1 receptor mediated role of dimethyltryptamine
in tissue protection, regeneration, and immunity.
-Gaujac et al. (2013) Application of analytical methods for the structural characterization and purity assessment of N,N-dimethyltryptamine, a potent psychedelic agent isolated from Mimosa tenuiflora inner barks
-Jiang et al. (2013) Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status
-Kochanowska et al. (2010) Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
-Mcllhenny et al. (2012) Methodology for determining major constituents of ayahuasca and their metabolites in blood
Salum-Pires et al. (2008) Gas Chromatographic Analysis of Dimethyltryptamine and b-Carboline Alkaloids in Ayahuasca, an Amazonian Psychoactive Plant Beverage
Shen et al. (2011) Nonlinear Pharmacokinetics of 5-Methoxy-N,N-dimethyltryptamine in Mice
Shen et al. (2010) Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics
 

Attachments

  • Shen+et+al+2011.pdf
    454.5 KB · Views: 0
  • Salum-Pires+et+al+2008.pdf
    127 KB · Views: 0
  • Mcllhenny+et+al+2012.pdf
    543 KB · Views: 0
  • Maside+et+al++2002.pdf
    211.8 KB · Views: 0
  • Kochanowska-Karamyan+ET+AL+2010.pdf
    259.6 KB · Views: 0
  • Jiang+et+al+2013.pdf
    1.9 MB · Views: 0
  • Gaujac+et+al+2013.pdf
    656.3 KB · Views: 0
  • Frecska+et+al+2013.pdf
    247.8 KB · Views: 0
  • Dos+Sntos+et+l+2012.pdf
    366 KB · Views: 0
  • Warren+et+al+2013.pdf
    71.1 KB · Views: 0
  • sHEN+ET+AL+201O.pdf
    319.9 KB · Views: 0
Back
Top Bottom